These data suggest that the systemic downregulation of activating receptors NKp30, NKp46, NKG2D, and DNAM-1 expression NK cell levels may be linked to an aberrant increase in plasma TGF-β1 levels during GC. Here, KLRK1 is linked to gastric cancer.